OriGene Technologies, Inc.
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right

spacer

Search Results

spacer

Your search returned 8 results.

Search:   Expanded Search
Genes match for XM_043151   Similar terms to XM_043151

42   Atl3   (DKFZP564J0863)

 Citation  Cited in Publication(s)

|<<     <<      >>     >>|   total pages:0
SKU   Category   Vector   Tag   Description   $ Price   Availability  
  SC116042     Human Clone pCMV6-XL5 No Tags (untagged)-Human DKFZP564J0863 protein (DKFZP564J0863) (10ug) 580 In Stock
SKU   Category   Vector   Description   $ Price   Availability  
  TR306957     Human shRNA pRS ATL3 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector 650 7-9 Days
  TF306957     Human shRNA pRFP-C-RS ATL3 - Human, 4 unique 29mer shRNA constructs in retroviral RFP vector 650 7-9 Days
  TL306957     Human shRNA pGFP-C-shLenti ATL3 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector 750 7-9 Days
  TG306957     Human shRNA pGFP-V-RS ATL3 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector 650 7-9 Days
  SR308598     Human siRNA ATL3 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each 390 2 weeks
  TL505881     Mouse shRNA pGFP-C-shLenti 5730596K20Rik - Mouse, 4 unique 29mer shRNA constructs in lentiviral GFP vector 750 7-9 Days
  TL703698     Rat shRNA pGFP-C-shLenti ATL3 - Rat, 4 unique 29mer shRNA constructs in lentiviral GFP vector 750 7-9 Days
Inc 5000 Healthcare Company Copyright © 2014 OriGene Technologies, Inc. All Rights Reserved. Legal Notices.
9620 Medical Center Dr., Suite 200, Rockville, MD 20850 • 1.888.267.4436

Reproduction of any materials from this website is strictly forbidden without permission.

All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title